Abstract
1/2008
vol. 5
Torakochirurgia
Non-small cell lung cancer: patients after pneumonectomy require longer anticoagulant prophylaxis than after lobectomy
Kardiochirurgia i Torakochirurgia Polska 2008; 5 (1): 31–37
Online publish date: 2008/03/20
Background:
Surgical treatment of cancer is associated with the risk of thromboembolism. The question is: might the range of lung resection in patients operated on for non-small cell lung cancer (NSCLC) have an influence on the serum anticoagulant protein expression?
Aim:
To compare the blood coagulation activation in patients after pneumonectomy and lobectomy based on concentration of selected proteins in serum.
Material and methods:
A prospective study was carried out among a group of 40 patients: Thirty of them underwent lobectomy and ten pneumonectomy. In all cases the serum level of tissue factor (TF), tissue factor pathway inhibitor (TFPI), tissue factor pathway inhibitor/activated factor X complex (TFPI/Xa), thrombin-antithrombin complex (TAT), L-selectin, E-selectin,
P-selectin were measured on the 1st and 7th postoperative day.
Results:
The results of selected protein levels obtained on the first day after surgery were similar in both groups. However, a significant increase of TF, TAT complex and E-selectin on the seventh postoperative day was detected in patients after pneumonectomy.
Conclusions:
Patients after pneumonectomy for NSCLC are at significantly higher risk of thromboembolism than patients after lobectomy. This suggests that antithrombotic prophylaxis should be prolonged in patients after pneumonectomy.
Keywords
lung cancer, lobectomy, pneumonectomy, thromboembolism
Coverage in
Integrated with
